MDXG - MIMEDX ALERT: Bragar Eagel & Squire P.C. is Investigating MiMedx Group Inc. on Behalf of MiMedx Stockholders and Encourages Investors to Contact the Firm | Benzinga
NEW YORK, Jan. 15, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against MiMedx Group, Inc. ("MiMedx" or the "Company") (NASDAQ:MDXG) on behalf of MiMedx stockholders. Our investigation concerns whether MiMedx has violated the federal securities laws and/or engaged in other unlawful business practices.
Click here to participate in the action.
On December 29, 2023, MiMedx issued a press release announcing that "[f]ollowing a routine inspection earlier in the year, the United States Food and Drug Administration (‘FDA') took the position that one of the Company's recently-launched placental-derived tissue products – AXIOFILL – does not meet ...